Regarding the hyperinflammatory response, elevated levels of pro-inflammatory interleukin-6 (IL-6) in COVID-19 patients have been associated with increased patient mortality, ICU admissions, and ventilator requirements [6]. The gene discussed is IL6; the disease is COVID-19.